Exclusive Channel Collaboration AgreementCollaboration Agreement • May 1st, 2013 • Soligenix, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 1st, 2013 Company Industry JurisdictionThis Exclusive Channel Collaboration Agreement (the “Agreement”) is made and entered into effective as of April 27, 2013 (the “Effective Date”) by and between Intrexon Corporation, a Virginia corporation with offices at 20358 Seneca Meadows Parkway, Germantown, MD 20876 (“Intrexon”), and Soligenix, Inc., a Delaware corporation having a place of business at 29 Emmons Drive, Suite C-10, Princeton, NJ 08540 (“Soligenix”). Intrexon and Soligenix may be referred to herein individually as a “Party”, and collectively as the “Parties.”
STOCK ISSUANCE AGREEMENTStock Issuance Agreement • May 1st, 2013 • Soligenix, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 1st, 2013 Company Industry JurisdictionThis Stock Issuance Agreement (“Agreement”) is made and entered into as of April 27, 2013 (the “Effective Date”), by and among Soligenix, Inc., a Delaware corporation (the “Company”) and Intrexon Corporation, a Virginia corporation (“Intrexon”).